1The importance of laminin at the blood-brain barrierSebok K.Halder, Arjun Sapkota, Richard Milner2557-25632Repair and regeneration of peripheral nerve injuries that ablate branch pointsJuliAnne E.Allgood, George D.Bittner, Jared S.Bushman2564-25683Cytokines,synaptic plasticity and network dynamics:a matter of balanceLaura Bellingacci, Jacopo Canonichesi, Andrea Mancini, Lucilla Parnetti, Massimiliano Di Filippo2569-25724Axonal growth inhibitors and their receptors in spinal cord injury:from biology to clinical translationSílvia Sousa Chambel, Célia Duarte Cruz2573-25815The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer's disease:a narrative reviewQian Zhang, Yaping Yan2582-25916Thinking outside the black box:are the brain endothelial cells the new main target in Alzheimer's disease?Enrique Estudillo, Adolfo López-Ornelas, Alejandro Rodríguez-Oviedo, Neptali Gutiérrez de la Cruz, Marco Antonio Vargas-Hernández, Adriana Jiménez2592-25987CDP-choline to promote remyelination in multiple sclerosis:the need for a clinical trialViktoria Gudi, Pawet Grieb, Ralf A.Linker, Thomas Skripuletz2599-26058Saliva:a challenging human fluid to diagnose brain disorders with a focus on Alzheimer's diseaseChristine Zürcher, Christian Humpel2606-26109Gut-microbiome-brain axis:the crosstalk between the vagus nerve,alpha-synuclein and the brain in Parkinson's diseaseJúlio César Claudino dos Santos, Leandro Freitas Oliveira, Felipe Micelli Noleto, Camilla Teixeira Pinheiro Gusm?o, Gerly Anne de Castro Brito, Glauce Socorro de Barros Viana2611-261410Animal models of vascularized nerve grafts:a systematic reviewFrancesca Toia, Daniele Matta, Federico De Michele, Roberto Pirrello, Adriana Cordova2615-261811Retinoprotective compounds,current efficacy,and future prospectiveRachele Marino, Rebecca Sappington, Marco Feligioni2619-262212Potential role of Lycium barbarum polysaccharides in glaucoma management:evidence from preclinical in vivo studiesYamunadevi Lakshmanan, Francisca Siu Yin Wong, Kwok-Fai So, Henry Ho-Lung Chan2623-263213Therapies for Tau-associated neurodegenerative disorders:targeting molecules,synapses,and cellsMiranda Robbins2633-263714Molecular chaperones in stroke-induced immunosuppressionHaoduo Qiao, Qing Xu, Yunfei Xu, Yao Zhao, Nina He, Jie Tang, Jie Zhao, Ying Liu2638-264415Role of exercise in the brain:focus on oligodendrocytes and remyelinationGrazia Maugeri, Velia D'Agata, Giuseppe Musumeci2645-264616GABAergic synaptic transmission and plasticity oscillate across sleep and wakeKunwei Wu, Wei Lu2647-264817Implications of Olig2 silencing in oligodendrocyte precursor cellsLi-Pao Fang, Xianshu Bai2649-265018Focus on LPA signaling:a promising therapeutic target to foster regeneration in immune-mediated neuropathiesFabian Szepanowski, Mark Stettner2651-265219The presence of functional blood vessels in the ischemic core provides a therapeutic target for stroke recoveryGary P.Morris, Brad A.Sutherland2653-265420Unexpected role of complement component 8 gamma chain in the inflamed brainJong-Heon Kim, Kyoungho Suk2655-2656 